read

SURVEILLANCE

A new Atlas of fertility treatment policies in Europe exposes inconsistencies in regulation and funding

A country-by-country review of policies and funding in ART finds that only four of 43 countries surveyed are rated as ‘excellent’ according to a nine-point list of treatment criteria; Fertility Europe and the European Parliamentary Forum for Sexual and Reproductive Rights call for a ‘game-changing’ shift in policies.

read

CAMPUS: GENETICS OF MALE INFERTILITY

The greater role of genetics in the cause and diagnosis of male infertility

A wide-ranging ESHRE Campus workshop organised by the SIGs Andrology and Reproductive Genetics looked at current and emerging approaches for the characterisation of various causes of male infertility, including tests in the genetics of idiopathic conditions, chromosomal anomalies – notably Klinefelter syndrome – and new molecular methods for investigation.

read

CAMPUS: FERTILITY PRESERVATION

At the crossroads of reproductive and regenerative medicine: new opportunities for preserving and restoring fertility

A September ESHRE Campus workshop organised by the SIGs Fertility Preservation and Stem Cells featured current and emerging approaches for fertility preservation, including oocyte in vitro maturation, cell therapy, reproductive tissue engineering and organ-on-chip approaches. Mina Popovic and Christiani Amorim from the SIG Stem Cells report from the two-day programme.

read

ESHRE 2021

Despite moderate evidence, use of add-ons in IVF remains ‘common’

A survey of more than 1500 IVF patients in Australia has found that most had used adjunct treatments alongside their standard treatment – and usually at additional cost.

read

WELL-BEING

How are you doing? Campus looks at the well-being of ART children and ART patients

A Campus workshop on the long-term impact of ART on the physical and psycho-social well-being of patients and children conceived through ART was held online in December; updates, from different perspectives, were largely reassuring.

ESHRE viral guidelineread

GUIDELINE: VIRAL INFECTION IN ART

ESHRE guideline on viral infection in ART puts emphasis on cutting risk of transmission

New guideline presents evidence on assisted reproduction in cases of six prevalent viruses - Hepatitis B (HBV), Hepatitis C (HCV), HIV, Human T-cell lymphotropic virus (HTLV I/II), Zika and HPV – with recommendations on virus transmission and prevention, and on factors affecting reproductive outcomes in couples with or without fertility problems.

KPIsread

PERFORMANCE INDICATORS

ESHRE reaches consensus on indicators of clinical performance in ART

Almost four years after ESHRE and Alpha Scientists reported their indicators for laboratory performance in ART, a new consensus has now been published by an ESHRE working group on indicators of clinical performance in ART.

read

REGULATION

ESHRE reaffirms its position on IVF add-ons, but little regulatory consensus on donor anonymity

ESHRE took part in the annual meeting of the UK’s Progress Educational Trust, publisher of the internationally read BioNews (www.bionews.org.uk). The ESHRE-sponsored and presented session was one of four on the meeting’s theme of regulation in fertility.

read

COVID-19 IN ART

‘Reassuring’ data from ESHRE’s COVID-19 ART pregnancy registry

Findings from the first analysis of ESHRE’s registry of COVID-19-affected ART pregnancies ‘offer reassurance’ that outcomes are similar to those found in spontaneous pregnancies.

read

IMPACT FACTORS

ESHRE journals further extend their impact factors

The latest impact factors, calculated for 2020 and released at the end of June, find Human Reproduction Update once again leading by far the categories of Obstetrics & Gynecology and Reproductive Biology, while Human Reproduction and Molecular Human Reproduction both make further gains.

Get notified of new articles with our ESHRE newsletter.

Sign up and never miss an update